Zhixiang Xin
Shanghai Changzheng Hospital(CN)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis(2021)168 cited
- → Isolation and Characterization of Collagen from the Skin of Deep‐Sea Redfish ( Sebastes mentella )(2007)124 cited
- → Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy(2022)106 cited
- → Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate(2018)67 cited
- → Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer(2022)65 cited
- → Astragalus Polysaccharide Attenuates Cisplatin‐Induced Acute Kidney Injury by Suppressing Oxidative Damage and Mitochondrial Dysfunction(2020)62 cited
- → Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone(2017)41 cited
- → Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer(2017)31 cited
- → ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers(2023)28 cited
- → Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome(2016)26 cited